Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01619553 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genetic Analysis of Keloids

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2025 to Dec 2030v14
  2. 2 versions Re-verified since Sep 19, 2023, no change to tracked fieldsv12-v13
  3. Enrollment target: 4000 to 7000
    • Publications: details revised at 1 of 3 entries
    v11
  4. 3 versions Re-verified since Nov 5, 2018, no change to tracked fieldsv8-v10
  5. Publications: 2 to 3v7
Show 5 earlier versionsHide 5 earlier versions
  1. 4 versions Re-verified since Aug 27, 2013, no change to tracked fieldsv3-v6
  2. Study Status, Outcome Measuresv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
UConn Health
38 trials monitored
See 2 trials at risk
Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.
Trial Details
NCT Number NCT01619553
Lead Sponsor UConn Health
Conditions
(from sponsor)		 Keloid
Related terms Cicatrix, Fibrosis, Keloid
Enrollment 7,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov